These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 16153857)

  • 21. Immunosuppressive mechanisms in human tumors: why we still cannot cure cancer.
    Gross S; Walden P
    Immunol Lett; 2008 Feb; 116(1):7-14. PubMed ID: 18164076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting.
    Gray A; Raff AB; Chiriva-Internati M; Chen SY; Kast WM
    Immunol Rev; 2008 Apr; 222():316-27. PubMed ID: 18364011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploiting dendritic cells and natural killer T cells in immunotherapy against malignancies.
    Fujii S
    Trends Immunol; 2008 May; 29(5):242-9. PubMed ID: 18372215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
    Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
    Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune escape of tumors: apoptosis resistance and tumor counterattack.
    Igney FH; Krammer PH
    J Leukoc Biol; 2002 Jun; 71(6):907-20. PubMed ID: 12050175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leukocyte infiltration in cancer creates an unfavorable environment for antitumor immune responses: a novel target for therapeutic intervention.
    Bronte V; Cingarlini S; Marigo I; De Santo C; Gallina G; Dolcetti L; Ugel S; Peranzoni E; Mandruzzato S; Zanovello P
    Immunol Invest; 2006; 35(3-4):327-57. PubMed ID: 16916757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of cytokine gene transfer into tumors on host cell infiltration and regression.
    McBride WH; Economou JS; Syljuåsen RG; Parrish C; Hackman D; Latham V; Chiang CS; Dougherty GJ
    Anticancer Res; 1996; 16(3A):1139-43. PubMed ID: 8702225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
    Khawli LA; Hu P; Epstein AL
    Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathways mediating the expansion and immunosuppressive activity of myeloid-derived suppressor cells and their relevance to cancer therapy.
    Talmadge JE
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5243-8. PubMed ID: 17875751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer immunologists and cancer biologists: why we didn't talk then but need to now.
    Prendergast GC; Jaffee EM
    Cancer Res; 2007 Apr; 67(8):3500-4. PubMed ID: 17413003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting costimulatory pathways for tumor immunotherapy.
    Ward RC; Kaufman HL
    Int Rev Immunol; 2007; 26(3-4):161-96. PubMed ID: 17558743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor cell loaded type-1 polarized dendritic cells induce Th1-mediated tumor immunity.
    Hokey DA; Larregina AT; Erdos G; Watkins SC; Falo LD
    Cancer Res; 2005 Nov; 65(21):10059-67. PubMed ID: 16267032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunobiology of head and neck cancer.
    Whiteside TL
    Cancer Metastasis Rev; 2005 Jan; 24(1):95-105. PubMed ID: 15785875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Less yin, more yang: confronting the barriers to cancer immunotherapy.
    Lizée G; Cantu MA; Hwu P
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5250-5. PubMed ID: 17875752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunosuppressive mechanisms in cancer: consequences for the development of therapeutic vaccines.
    Gross S; Geldmacher A; Sharav T; Losch F; Walden P
    Vaccine; 2009 May; 27(25-26):3398-400. PubMed ID: 19200836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigen-nonspecific activation of CD8+ T lymphocytes by cytokines: relevance to immunity, autoimmunity, and cancer.
    Ramanathan S; Gagnon J; Ilangumaran S
    Arch Immunol Ther Exp (Warsz); 2008; 56(5):311-23. PubMed ID: 18836862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Taming cancer by inducing immunity via dendritic cells.
    Palucka AK; Ueno H; Fay JW; Banchereau J
    Immunol Rev; 2007 Dec; 220():129-50. PubMed ID: 17979844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Host immune responses to cervical cancer.
    Patel S; Chiplunkar S
    Curr Opin Obstet Gynecol; 2009 Feb; 21(1):54-9. PubMed ID: 19125004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators.
    Ben-Baruch A
    Semin Cancer Biol; 2006 Feb; 16(1):38-52. PubMed ID: 16139507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.